Investment firm Roc Partners has stepped upped its bidding game for agricultural real estate manager Vitalharvest (ASX:VTH).
The offer of $1.16 for every Vitalharvest share came in the midst of a bidding contest with Macquarie Infrastructure and Real Assets. This has placed Roc in pole position in the race to acquire assets of Vitalharvest (ASX:VTH), as it is 4 cents ahead of Macquarie’s offer. The $220 million-rated owner of orchards has given Macquarie till next Thursday to challenge their rival’s bid.
Shares in Vitalharvest Freehold Trust (ASX:VTH) are trading 3.95 per cent higher at $1.18
09 Jul 2020 - Treasury Wine Estates (ASX:TWE) has posted a 21% decline in FY20 EBITS, with regional declines of approximately 14 per cent in Asia, 37 per cent in the Americas, 16 per cent in ANZ and 18 per cent in Europe, the Middle East and Africa.
23 Mar 2021 - Whitehaven Coal (ASX:WHC) reports that Newcastle Coal Infrastructure Group has suspended shiploading at the Port of Newcastle after a structural assessment of its shiploader identified faults.
17 Mar 2020 - Coca-Cola Amatil (ASX:CCL) say given the significant uncertainty in relation to the duration and impact of the COVID-19 pandemic, we no longer feel it is appropriate to continue to provide earnings guidance.
24 Jan 2020 - Genworth Mortgage lnsurance Australia (ASX:GMA) today announced that Pauline Blight-Johnston has been appointed Chief Executive Officer and Managing Director.
22 Apr 2020 - Fiducian Financial Services, the financial planning subsidiary of Fiducian Group (ASX:FID) has facilitated the acquisition of a regional financial planning business for its franchise office located in Gippsland, Victoria.
28 Jan 2020 - Electro Optic Systems Holdings (ASX:EOS) has executed an agreement to acquire all of the business and assets of Audacy Corporation, a space communications company based in the US.
25 Jun 2020 - CSL (ASX:CSL) has agreed to acquire from uniQure exclusive global license rights to commercialise an adeno-associated virus gene therapy program, for the treatment of haemophilia B.